Surrogacy Fraud Plea Deal Reached; Manitoba Law Pushed for Reform

A woman accused in a surrogacy fraud case has accepted a plea deal and will avoid jail time, according to WENY News. The outcome has drawn sharp criticism from foster family advocates, who expressed outrage at the sentencing. The case was previously covered in the context of indictment charges filed against the Camas Surrogacy Center.

Plea deals in fraud cases often mean limited restitution for victims. If you were affected by this agency, talk to your attorney now about what civil options may still be available to you.

A Manitoba couple is calling for changes to the province's surrogacy laws following their son's birth, CBC reports. The story follows a Winnipeg couple who previously filed a complaint over birth registration laws after their surrogacy journey. The couple's experience has highlighted gaps in how Manitoba's legal framework handles surrogacy-related documentation.

Canadian surrogacy law varies significantly by province. If you are pursuing surrogacy in Manitoba or another Canadian province, verify how parentage and birth registration will be handled before your surrogate gives birth, not after.

The Taipei Times reports that a Chinese promoter of surrogacy services has been deported from Taiwan. The deportation is part of a broader crackdown on individuals facilitating surrogacy arrangements, which is prohibited in Taiwan. This follows yesterday's coverage of Taiwanese authorities deporting Chinese nationals for surrogacy promotion.

Worth watching as Taiwan and other Asian jurisdictions tighten enforcement, the ripple effects on where international intended parents can access services are becoming more pronounced.

New Zealand actor Harry McNaughton, formerly of the show Shorty, has spoken publicly about the emotional complexity of having a child through surrogacy, telling the NZ Herald that the process came with feelings of guilt. McNaughton's candid account touches on the psychological weight that intended parents can carry even after a successful surrogacy journey. The interview adds a personal dimension to ongoing public conversations about surrogacy's emotional landscape.

This one is a good reminder that a baby arriving safely does not mean the emotional journey is over. The guilt McNaughton describes is something many intended parents report and rarely talk about openly.

Yahoo Finance reports that Taiwan-based fertility specialists will present new perspectives on IVF treatment for patients who have experienced repeated IVF failures, at an upcoming event in South Korea. The session is aimed at exploring what options remain available after multiple unsuccessful cycles. No further clinical details were provided in the article.

If you are navigating repeated IVF failures, cross-border consultations are increasingly common and worth exploring, though protocols and legal frameworks vary widely by country.

Embryo Genetic Testing: PGT-A and What It Reveals

When a fertility clinic creates embryos through IVF, one of the most consequential decisions a care team and intended parents face together is whether to test those embryos before transfer. Preimplantation genetic testing for aneuploidies — most often called PGT-A — is a screening tool designed to look at an embryo's chromosomes and count whether all 23 pairs are present and correctly structured.

The testing process begins once an embryo has grown for five or six days, reaching a stage called the blastocyst. At that point, an embryologist uses a delicate technique to remove a small cluster of cells — typically five to ten — from the outer layer of the embryo, which is the tissue that will eventually become the placenta rather than the baby itself. Those cells are sent to a genetics laboratory while the embryo is frozen and kept safely in storage.

Results come back describing each embryo as either euploid, meaning the expected number of chromosomes is present, or aneuploid, meaning there is an extra or missing chromosome. In practice, euploid embryos are generally prioritized for transfer because chromosomal abnormalities are a leading cause of miscarriage and failed implantation. Some embryos are also reported as mosaic, meaning a mixture of normal and abnormal cells was detected, and those results require a more nuanced conversation with a reproductive endocrinologist.

It is worth knowing that PGT-A is not universally recommended. Some reproductive endocrinologists argue that the biopsy itself carries a small risk, that mosaic embryos can sometimes lead to healthy pregnancies, and that the test does not screen for all possible genetic conditions. For intended parents weighing this decision, an open, unhurried conversation with your medical team about your specific embryo cohort and history is the most important step you can take.